80061670 - Johns Hopkins Retinal Degeneration and Visual Electrophysiology 2023 Conference

Friday, September 15, 2023, 8:00 AM - Saturday, September 16, 2023, 5:00 PM, Johns Hopkins University School of Medicine, Turner Bldg., Baltimore, MD


This two-day conference is designed to provide an update on the latest exciting and cutting-edge developments in the field of retinal degeneration, repair, and regeneration, including recent advances in stem cells and gene therapy, cellular and molecular mechanisms of disease, outcome measures, natural history, nanomedicine, systemic manifestations, surgery and delivery, ethics and global perspectives. The program includes a refresher course on visual electrophysiology for clinicians and researchers

1. Recall cellular and molecular basis of selected IRDs, with an emphasis on mechanistic insights that inform treatment strategies and outcome measures.
2. Review recommendations from the International Society of Clinical Electrophysiology of Vision (ISCEV) regarding visual neurophysiology testing.
3. Review structural and functional outcome measures of IRDs, including those relevant to subjects with ultra-low vision.
4. Review data and results from Phase I, II, and III clinical trials, and translational studies, with an emphasis on stem cells, gene therapy, and other treatment approaches.
5. Review aspects relating to equitable access to clinical care and research for IRD patients, and ethical considerations unique to people with vision loss due to IRDs.

Registration Fees:	Early Bird Rates Until 6/30/2023	Regular Rates After 6/30/2023
Physician/Scientist/Optometrist/Industry	$585	$685
Allied Health Professional(RN/NP/PA)	$485	$585
Trainees(Student/Resident/Fellow/Post-Doc)	$75	$100

ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 12.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER CREDIT
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

PAs may claim a maximum of 12.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

The Johns Hopkins University has approved this activity for 12.50 contact hours for non-physicians.

POLICY ON PRESENTER AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies in place to identify and mitigate relevant conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

You are not logged in.

Please click the button below to login or create a new account before continuing.

HOTEL RESERVATION CUT-OFF DATE: AUGUST 15, 2023
The Residence Inn Baltimore is located on the Johns Hopkins Medical Campus. Make your reservation at www.marriott.com or call the hotel directly and specify that you are attending the Johns Hopkins Retinal Degeneration conference to receive the special group rate of $139 for one bedroom king suite, plus tax. On-site parking is available at the hotel at an additional charge. Check-in time is 4:00 p.m. Check-out time is 12:00 p.m.

Mitigation of Relevant Financial Relationships

Johns Hopkins University adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.